Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is using gene therapy that could turn back the clock on ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before. Earlier this week, Life Biosciences, a biotech company focused on reversing age-related ...

Company has now raised $6 million since founding to advance mRNA-based therapeutics designed to turn tumor cells into immune-activating cells SAN CARLOS, Calif., May 27, 2026 — Reprogram Biosciences, ...

The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise and powerful than ever. From curing genetic diseases to designing the next ...

This video features a curated selection of funny moments captured in real-life situations. From spontaneous reactions and small mishaps to everyday humor, each clip highlights authentic and relatable ...

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm ...

The “Welcome to Fabulous Las Vegas” sign glowed pink and green to welcome Alpha Kappa Alpha’s 72nd International Boule. LVMPD’s Bolden Area Command hosted “Splash with the Badge” at the Bill and ...

For those hoping to cure death, and they are legion, a 2016 experiment at the Salk Institute for Biological Studies in San Diego has become liminal — the moment that changed everything. The experiment ...

The 2025 Corvette is the subject of a new service bulletin from General Motors, related to a Body Control Module (BCM) problem that causes a check engine light to display. GM is now offering a fix for ...

The ‘90s saw music videos elevated to an art form. In the previous decade, artists were mainly focused on eye-candy – performance footage, silly antics and video vixens were some of the most common ...

Veo has launched in private preview, while OpenAI’s Sora is still nowhere to be seen. Veo has launched in private preview, while OpenAI’s Sora is still nowhere to be seen. is a news writer focused on ...